Pay in 4 interest-free payments of $5.44 Learn more
Ships within 48 hours · Estimated delivery Oct 10 - Oct 15
Size View COA 20mg View COA 30mg View COA 40mg Research reference Overview Retatrutide (LY-3437943) is an investigational triple-receptor agonist that combines activity at the GLP-1, GIP and glucagon receptors in a single 39-residue peptide backbone
It is generally limited to clinical trial or approved research channels
Both the Wegovy pill and shot may cause side effects, though they are generally mild and temporary
Reconstitute with sterile or bacteriostatic water
Excess adiposity, particularly visceral fat, is associated with reduced GLP-1 secretion and impaired incretin effect
US$ 25.37
US$ 21.98
US$ 29.88
US$ 25.20
